Literature DB >> 21095276

Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries.

Robb D Kociol1, Bradley G Hammill, Gregg C Fonarow, Winslow Klaskala, Roger M Mills, Adrian F Hernandez, Lesley H Curtis.   

Abstract

BACKGROUND: Clinical registries are used increasingly to analyze quality and outcomes, but the generalizability of findings from registries is unclear.
METHODS: We linked data from the Acute Decompensated Heart Failure National Registry (ADHERE) to 100% fee-for-service Medicare claims data. We compared patient characteristics and inpatient mortality of linked and unlinked ADHERE hospitalizations; patient characteristics, readmission, and postdischarge mortality of linked ADHERE patients to a random 20% sample of Medicare beneficiaries hospitalized for heart failure; and characteristics of Medicare sites participating and not participating in ADHERE.
RESULTS: Among 135,667 ADHERE records for eligible patients ≥ 65 years, we matched 104,808 (77.3%) records to fee-for-service Medicare claims, representing 82,074 patients. Linked hospitalizations were more likely than unlinked hospitalizations to involve women and white patients; there were no meaningful differences in other patient characteristics. In-hospital mortality was identical for linked and unlinked hospitalizations. In Medicare, ADHERE patients had slightly lower unadjusted mortality (4.4% vs 4.9% in-hospital, 11.2% vs 12.2% at 30 days, 36.0% vs 38.3% at 1 year [P < .001]) and all-cause readmission (22.1% vs 23.7% at 30 days, 65.8% vs 67.9% at 1 year [P < .001]). After risk adjustment, modest but statistically significant differences remained. ADHERE hospitals were more likely than non-ADHERE hospitals to be teaching hospitals, have higher volumes of heart failure discharges, and offer advanced cardiac services.
CONCLUSION: Elderly patients in ADHERE are similar to Medicare beneficiaries hospitalized with heart failure. Differences related to selective enrollment in ADHERE hospitals and self-selection of participating hospitals are modest.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21095276     DOI: 10.1016/j.ahj.2010.07.020

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  40 in total

1.  [Dobutamine in severe heart failure. More questions than answers].

Authors:  U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-01-29       Impact factor: 0.840

Review 2.  Care-seeking decisions for worsening symptoms in heart failure: a qualitative metasynthesis.

Authors:  S E Ivynian; M DiGiacomo; P J Newton
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

3.  Atrial fibrillation: a leading cause of heart failure-related hospitalizations; a dual epidemic.

Authors:  Asrar Ahmed; Waqas Ullah; Ishtiaq Hussain; Sohaib Roomi; Yasar Sattar; Faizan Ahmed; Rehan Saeed; Ammar Ashfaq
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

4.  The Bi-directional Impact of Two Chronic Illnesses: Heart Failure and Diabetes - A review of the Epidemiology and Outcomes.

Authors:  Patrick Campbell; Selim Krim; Hector Ventura
Journal:  Card Fail Rev       Date:  2015-04

5.  Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.

Authors:  Nisha Bansal; Leila Zelnick; Zeenat Bhat; Mirela Dobre; Jiang He; James Lash; Bernard Jaar; Rupal Mehta; Dominic Raj; Hernan Rincon-Choles; Milda Saunders; Sarah Schrauben; Matthew Weir; Julie Wright; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2019-06-04       Impact factor: 24.094

6.  Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE Registry.

Authors:  Zubin J Eapen; Xiaojuan Mi; Gregg C Fonarow; Soko Setoguchi; Jonathan P Piccini; Roger M Mills; Winslow Klaskala; Lesley H Curtis; Adrian F Hernandez
Journal:  J Atr Fibrillation       Date:  2013-12-31

7.  All-Payer Analysis of Heart Failure Hospitalization 30-Day Readmission: Comorbidities Matter.

Authors:  Jonathan D Davis; Margaret A Olsen; Kerry Bommarito; Shane J LaRue; Mohammed Saeed; Michael W Rich; Justin M Vader
Journal:  Am J Med       Date:  2016-08-31       Impact factor: 4.965

8.  A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience.

Authors:  Leor Perl; Elina Soifer; Jozef Bartunek; Dedi Erdheim; Friedrich Köhler; William T Abraham; David Meerkin
Journal:  J Cardiovasc Transl Res       Date:  2019-01-02       Impact factor: 4.132

9.  Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.

Authors:  Paul L Hess; Melissa A Greiner; Gregg C Fonarow; Winslow Klaskala; Roger M Mills; Soko Setoguchi; Sana M Al-Khatib; Adrian F Hernandez; Lesley H Curtis
Journal:  Clin Cardiol       Date:  2012-10-15       Impact factor: 2.882

Review 10.  Management of Patients Admitted with Acute Decompensated Heart Failure.

Authors:  Selim R Krim; Patrick T Campbell; Sapna Desai; Stacy Mandras; Hamang Patel; Clement Eiswirth; Hector O Ventura
Journal:  Ochsner J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.